Carr Daniel B

Avg. Two Year Performance

(31%) Avg. Purchase Return
(14%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return16%36%51%10%(31%)
Purchase Success Rate1 of 22 of 22 of 22 of 21 of 2
Average Sale Return16%(< 1%)0%0%0%
Sale Success Rate1 of 20 of 20 of 20 of 20 of 2

Javelin Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

President and CMO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--